Lackner, Josh2009-05-062009-05-062009-05-06https://hdl.handle.net/11299/49800The information provided in this handout does not necessarily reflect the views of the University of Minnesota Medical School physicians and faculty. These materials are provided for informational purposes only and are in no way intended to take the place of the advice and recommendations of your personal health care provider. You use the information provided in these handouts at your own risk.The most recent assessment of available evidence on lung cancer screening with a sensitive modality (computed tomography) found that we cannot conclude that such screening provides a mortality benefit. The main reason for this, is that there is no available trial that compares CT screening to no screening over an adequate duration of time. Of note, false positive results were very common and tumors found on screening had different characteristics from those found clinically.en-USScreeningLung CancerSmokingOther